Intracellular metabolism and action of acyclic nucleoside phosphonates on DNA replication

Molecular Pharmacology

Volumn 52, Issue 1, 1997, Pages 63-68

  Pisarev, Vladimir M ^a   Lee, Suk Hee ^a   Connelly, Michele C ^a   Fridland, Arnold ^a  

^a ST JUDE CHILDREN S RESEARCH HOSPITAL   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

9 (2 PHOSPHONYLMETHOXYETHYL)GUANINE; ACYCLIC NUCLEOSIDE; ADEFOVIR; DNA; DNA POLYMERASE; DRUG METABOLITE; PHOSPHONIC ACID DERIVATIVE; UNCLASSIFIED DRUG;

ARTICLE; CELL METABOLISM; DNA REPLICATION; DRUG ACCUMULATION; DRUG CYTOTOXICITY; DRUG MECHANISM; DRUG METABOLISM; ENZYME INHIBITION; HUMAN; HUMAN CELL; PRIORITY JOURNAL;

EID: 0030754125     PISSN: 0026895X     EISSN: None     Source Type: Journal    
DOI: 10.1124/mol.52.1.63     Document Type: Article

References (24)

1. Naesens, I., J. Balzarini, and E. De Clercq. Therapeutic potential of PMEA as an antiviral drug. Rev. Med. Virol.. 16:147-159 (1994).
2. Freeman, S., and J. M. Gardiner. Acyclic nucleosides as antiviral compounds. Mol. Biotechnol. 3:125-137 (1996).
3. Hoover, E. A., J. P. Ebner, N. S. Zeidner, and J. I. Mullins. Early therapy of feline leukemia virus infection (FeLV-FAIDS) with 9-(2-phosphonylmethoxyethyl)adenine (PMEA). Antiviral Res. 16:77-92 (1991).
4. Tsai, C. C., K. E. Follis., A. Sabo, R. Grant, and N. Bischofberger. Efficacy of 9-(2-phosphonylmethoxyethyl)adenine treatment against chronic simian immunodeficiency virus infection in macaques. J. Infect. Dis. 171: 1338-1343 (1994).
5. Tsai, C. C., K. E. Follis, A. Sabo, T. W. Beck, R. F. Grant, N. Bischofberger, R. Beneviste, and R. Black. Prevention of simian immunodeficiency virus infection in macaques by 9-(2-phosphonylmethoxypropyl)adenine (PMPA). Science (Washington D. C.) 270:1197-1199 (1995).
6. Neyts, J., and E. De Clercq. Mechanism of action of acyclic nucleoside phosphonates against herpes virus replication. Biochem. Pharmacol. 47: 39-41 (1994).
7. Cherrington, J. M., S. J. W. Allen, N. Bischofberger, and M. S. Chen. Kinetic interaction of diphosphates of 9-(2-phosphonylmethoxyethyl)adenine and other anti-HIV active purine congeners with HIV reverse transcriptase and human DNA polymerases α, β and γ. Antiviral Chem. Chemother. 6:217-221 (1995).
8. Rose, W. C., A. R. Crosswell, J. J. Bronson, and J. C. Martin. In vivo antitumor activity of 9-[(2-phosphonylmethoxy)ethyl]guanine and related phosphonate nucleotide analogues. J. Natl. Cancer Inst. 82:510-512 (1990).
9. Robbins, B. L., M. C. Connelly, D. R. Marshall, R. V. Srinivas, and A. Fridland. A human T lymphoid cell variant resistant to the acyclic nucleoside phosphonate 9-(2-phosphonylmethoxyethyl)adenine shows a unique combination of a phosphorylation defect and increased efflux of the agent. Mol. Pharmacol. 47:391-397 (1995).
10. Krieder, J. W., K. Balogh, R. O. Olson, and J. C. Martin. Treatment of latent rabbit and human papillomavirus infection with 9-(2-phosphonylmethoxyethyl)guanine (PMEG). Antiviral Res. 14:51-58 (1990).
11. Ho, H.-T., K. L. Woods, S. K. Konrad, H. DeBoeck, and M. J. M. Hitchcock. Cellular metabolism and enzymatic phosphorylation of 9-(2-phosphorylmethoxyethyl) guanine (PMEG), a potent antiviral agent, in Innovations in Antiviral Development and the Detection of Virus Infection (T. M. Block, ed.). Plenum Press, New York, 159-166 (1992).
12. Kramata, P., I. Votruba, B. Otova, and A. Holy. Different inhibitory potencies of acyclic phosphonomethoxyalkyl nucleotide analogs toward DNA polymerases α, β and ∈. Mol. Pharmacol 49:1005-1011 (1996).
13. Lee, S.-H., T. Eki, and J. Hurwitz. Synthesis of DNA containing the simian virus 40 origin of replication by the combined action of DNA polymerases α and &. Proc. Natl. Acad. Sci. USA 86:7361-7365 (1989).
14. Yang, R., and C. Lu. Developmental activity variations of DNA polymerases alpha, delta, epsilon in mouse forebrains and spleens. Science (Washington D. C.) 38:1237-1245 (1995).
15. Hurwitz, J., F. B. Dean, A. D. Kwong, and S.-H Lee. The in vitro replication of DNA containing the SV40 origin. J. Biol. Chem. 265:18043-18046 (1990).
16. Lee, S.-H., and D. K. Kim. The role of the 34-kDa subunit of human replication protein A in simian virus 40 DNA replication in vitro. J. Biol. Chem. 270:12801-12807 (1995).
17. Wobbe, C. R., F. Dean, L. Weissbach, and J. Hurwitz. In vitro replication of duplex circular DNA containing the simian virus 40 DNA origin site. Proc. Natl. Acad. Sci. USA 82:5710-5714 (1985).
18. Ho, H.-T., K. L. Woods, J. J. Bronson, H. De Boeck, J. C. Martin, and M. J. M. Hitchcock. Intracellular metabolism of the anti-herpes agent (S)-1-[3-hydroxy-2-(phosphonylmethoxy)propyl]cytosine. Mol. Pharmacol. 41: 197-202 (1992).
19. Connelly, M. C., B. L. Robbins, and A. Fridland. Mechanism of uptake of the phosphonate analog 1-(s)-(3-hydroxy-2-phosphonylmethoxypropyl)cytosine (HPMPC) in Vero cells. Biochem. Pharmacol. 46:1053-1057 (1993).
20. Robbins, B. L., J. Greenhaw, M. C. Connelly, and A. Fridland. Metabolic pathways for activation of the antiviral agent 9-(2-phosphonylmethoxyethyl)adenine in human lymphoid cells. Antimicrob. Agents Chemother. 39:2304-2308 (1995).
21. Sambrook, J., E. Fritsch, and T. Maniatis. Molecular Cloning: A Laboratory Manual. Ed. 2. Cold Spring Harbor Laboratory Press, Cold Spring Harbor, NY (1989).
22. Balzarini, J., P. Hao, P. Herdwijn, D. G. Johns, and E. De Clercq. Intracellular metabolism and mechanism of anti-retrovirus action of 9-(2-phosphonylmethoxyethyl) adenosine, a potent anti-human immunodeficiency virus compound. Proc. Natl. Acad. Sci. USA 88:1499-1503 (1991).
23. Zlotkin, T., G. Kafmann, Y. Jiang, M. Lee, L. Uitto, J. Syväoja, I. Dornreiter, E. Fanning, and T. Nethand. DNA polymerase epsilon may be dispensable for SV40 but not cellular-DNA replication. EMBO J 15:2298-2305 (1996).
24. Ilsley, D. D., S.-H. Lee, W. H. Miller, and R. D. Kuchta. Acyclic guanosine analogs inhibit DNA polymerase α, δ and ∈ with very different potencies and have unique mechanism of action. Biochemistry. 34:2504-2510 (1995).